October 22, 2020
Briefly
- We (well, the world) might well be getting the first Covid vaccine in the next few months — but what about all the runners-up, which we may need too?
- Graph of Auckland public transport usage this year, from Greater Auckland (click to embiggen)
.
As you’d expect, near zero for the lockdown periods, and the current track repairs are really hitting train use
- “RealRisk” is a new tool for visualising absolute vs relative risks, from David Spiegelhalter and the Winton Centre for Risk and Evidence Communication
- Tim Harford welcoming World Statistics Day (it only happens every five years)
- The Canberra Times needs to have its pie-chart licence revoked
Thomas Lumley (@tslumley) is Professor of Biostatistics at the University of Auckland. His research interests include semiparametric models, survey sampling, statistical computing, foundations of statistics, and whatever methodological problems his medical collaborators come up with. He also blogs at Biased and Inefficient See all posts by Thomas Lumley »
I was wondering to what extent the UK push for challenge trials was in response to this question:
https://news.yahoo.com/uk-backs-human-challenge-studies-075816458.html
As that would be an awfully convenient setting to do comparative effectiveness. It would reduce the questions about whether differences in efficacy were due to source population differences, as you could randomize within the trial population.
Of course, the news articles aren’t being very forthcoming on what the scientific plan is, but this seems to me (personal opinion only) the only information that could possibly be valuable enough to deliberately infect people with a life-threatening virus.
4 years ago
I was really rooting for Unsure to get the role, think he could have used the vote of confidence!
4 years ago